Drug
Gadolinium Based Contrast Agent
Gadolinium Based Contrast Agent: highest development phase Not Applicable, developed by Hyperfine. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Hyperfine
Trials
| Drug | Phase | Indication |
|---|---|---|
| Gadolinium-Based Contrast Agent (GBCA) NCT07296263 | Not Applicable | Intra-axial Tumors |
Latest
No recent events.
Follow Gadolinium Based Contrast Agent on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.